When compared with the control group, the percentages of cells undergoing apoptosis increased significantly in the PCa+Docetaxel, PCa+LDH-A inhibitor, and PCa+LDH-A inhibitor+Docetaxel combination groups (p < 0.001, p < 0.01, and p < 0.001 respectively) (Figure 2 A-B). The gene discussed is LDHA; the disease is posterior cortical atrophy.